GLP-1 weight-loss study finds users moved less after starting treatment

An Endocrine Society ENDO 2026 analysis using NIH All of Us and Fitbit data found lower step counts and fewer moderate-to-vigorous activity minutes after adults with obesity started GLP-1 medication.









